{"cik":1610820,"taxonomy":"ifrs-full","tag":"ResearchAndDevelopmentExpense","label":null,"description":null,"entityName":"BRIACELL THERAPEUTICS CORP.","units":{"USD":[{"start":"2019-07-30","end":"2019-08-01","val":4002676,"accn":"0001493152-21-028949","fy":2021,"fp":"FY","form":"40-F/A","filed":"2021-11-16","frame":"CY2019Q2I"},{"start":"2019-08-02","end":"2020-07-31","val":2425838,"accn":"0001493152-21-028949","fy":2021,"fp":"FY","form":"40-F/A","filed":"2021-11-16","frame":"CY2020"},{"start":"2020-08-01","end":"2021-01-31","val":314655,"accn":"0001493152-22-006886","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-03-15"},{"start":"2020-11-01","end":"2021-01-31","val":165592,"accn":"0001493152-22-006886","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-03-15","frame":"CY2020Q4"},{"start":"2020-08-01","end":"2021-04-30","val":1440080,"accn":"0001493152-22-016599","fy":2022,"fp":"Q3","form":"6-K","filed":"2022-06-13"},{"start":"2021-02-01","end":"2021-04-30","val":1125425,"accn":"0001493152-22-016599","fy":2022,"fp":"Q3","form":"6-K","filed":"2022-06-13","frame":"CY2021Q1"},{"start":"2020-08-01","end":"2021-07-31","val":1315496,"accn":"0001493152-21-028949","fy":2021,"fp":"FY","form":"40-F/A","filed":"2021-11-16","frame":"CY2021"},{"start":"2021-08-01","end":"2022-01-31","val":2609191,"accn":"0001493152-22-006886","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-03-15"},{"start":"2021-11-01","end":"2022-01-31","val":1733555,"accn":"0001493152-22-006886","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-03-15","frame":"CY2021Q4"},{"start":"2021-08-01","end":"2022-04-30","val":5152672,"accn":"0001493152-22-016599","fy":2022,"fp":"Q3","form":"6-K","filed":"2022-06-13"},{"start":"2022-02-01","end":"2022-04-30","val":2543481,"accn":"0001493152-22-016599","fy":2022,"fp":"Q3","form":"6-K","filed":"2022-06-13","frame":"CY2022Q1"}]}}